With industrial research increasingly under pressure to produce rapid profits, and universities rightly concerned with primary research, can university spin-off companies fill the gap between invention and commercialization?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Noll, A. M. Nature Mater. 5, 337–338 (2006).
Alivisatos, A. P. Science 271, 933–937 (1996).
Brus, L. E. J. Chem. Phys. 79, 5566–5571 (1983).
Pradhan, N., Goorskey, D., Thessing, J. & Peng, X. J. Am. Chem. Soc. 127, 17586–17587 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peng, X. University spin-offs: Opportunity or challenge?. Nature Mater 5, 923–925 (2006). https://doi.org/10.1038/nmat1790
Issue Date:
DOI: https://doi.org/10.1038/nmat1790
This article is cited by
-
The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases
Clinical Pharmacology & Therapeutics (2012)
-
The business of science
Nature Materials (2006)
